Skip to content

The effect of intravenous syntocinone injection on the third stage of labor

The effect of intravenous syntocinone injection on the third stage of labor in pregnant women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110103005534N2
Enrollment
100
Registered
2022-07-23
Start date
2022-07-16
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery outcome. Outcome of delivery

Interventions

Intervention 1: Intervention group: 10 units of Oxytocin is injected into the umbilical vein (near the entrance to the vagina intraitus) immediately after the baby is born and the umbilical cord is cu

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Term pregnancy (37-42 weeks) Single pregnancy vertex presentation Age 18- 35 years Number of deliveries 0-2 Spontaneous onset of labor pains No chronic diseases (heart disease, hypertension and diabetes) Absence of high-risk pregnancies (gestational hypertension, decreased fetal motility, fetal death, amniotic polyhydramnios and oligohydramnios known by ultrasound, rupture of membranes more than 12 hours, history of infertility) alive fetus Birth weight between 4500-2500 grams Prenatal hemoglobin more than 10 grams per deciliter absence of placenta previa absence of placenta abruption No history of any bleeding during pregnancy No curettage history Absence of any scar on the uterus Do not take anticoagulants

Exclusion criteria

Exclusion criteria: Reluctance to continue participating in the study Disorders in the progress of labor prolong labor (more than 20 hours) precipitate labor( less than 3 hours) Blood pressure of 140/90 mm Hg or more during the study Disorders in labor (prolong labor, dystocia, placenta abruption , umbilical cord prolapse, etc.) Manual Removal of the Placenta Abnormal fetal heart rate patterns leading to cesarean section Lack of progress of labor that leads to cesarean section Expansion of the episiotomy Excessive postpartum hemorrhage (more than 500 cc) Using vacuum postpartum re-manipulation of the perineum

Design outcomes

Primary

MeasureTime frame
Hemoglobin and hematocrit levels. Timepoint: Before intervention and 6 hours after delivery. Method of measurement: Using a microcentrifuge.;Duration of the third stage of labor. Timepoint: Third stage of labor. Method of measurement: On a minute basis.;Pain intensity in the third stage of labor. Timepoint: Third stage of labor. Method of measurement: Visual pain ruler.;Systolic and diastolic blood pressure 30 and 60 minutes after delivery. Timepoint: 30 and 60 minutes after delivery. Method of measurement: Standard mercury blood pressure monitor.;Placenta characteristics (weight - diameter - exit method - anomalies). Timepoint: After delivery of placenta. Method of measurement: observation-meter-scale.;Manual Removal of the Placenta. Timepoint: After placenta delivery. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Azima

Shiraz University of Medical Sciences

azimas@sums.ac.ir+98 71 3647 4258

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026